HEMOGLOBIN SUBTYPE - NEONATAL SCREENING - ANVISA Registration 80020690277

Access comprehensive regulatory information for HEMOGLOBIN SUBTYPE - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80020690277 and manufactured by BIO-RAD LABORATORIES, INC. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Jan 30, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA, WALLAC OY, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.